文献速递皮肤肿瘤

2000-2014年NIH资助的皮肤癌相关行为与结局研究:SCI-3C项目分析

Research on Skin Cancer-Related Behaviors and Outcomes in the NIH Grant Portfolio, 2000-2014: Skin Cancer Intervention Across the Cancer Control Continuum (SCI-3C).
PubMed 文献 · JAMA Dermatol · 2017-01-01

该研究对2000至2014年NIH资助的皮肤癌相关行为研究进行了 portfolio 分析,共112份申请中40份(35.7%)获得资助,其中31项为干预研究。资助项目多集中于预防,而检测、生存期及诊断治疗相关行为研究较少,且理论、技术和环境干预的潜力未充分利用。

要点

  • 皮肤癌行为研究资助成功率35.7%,高于NIH总体约18%。
  • 干预研究多针对预防,检测和生存期研究少。
  • 理论和技术使用常见,但未充分整合到干预中。

核心结论

  • 皮肤癌行为科学资助成功率与NIH总体相比较为有利,男女研究者成功率无统计差异。
  • 行为研究在皮肤癌控制连续体的各环节存在缺口,临床相关目标干预较少。

研究设计与样本

  • 对2000-2014年NIH资助申请进行portfolio分析,共112份符合标准,其中40份获资助。

主要发现

  • 112份申请中40份(35.7%)获资助,其中31项为干预研究。
  • 男性研究者成功率为33.3%,女性为37.3%,无显著差异;R01资助频率分别为36.7%和28.1%。
  • 干预研究中24项针对预防,3项针对检测,4项针对生存期,无针对情绪后遗症或依从性的研究。
  • 超过75%的资助项目使用了理论和技术,但技术能力未充分利用。
  • 所有传播类资助均包含政策或环境干预,其他项目较少使用;19.4%包含政策实施,25.8%提出建筑环境改变。

临床怎么用

  • 提示应加强皮肤癌检测、生存期及诊断治疗相关行为研究。
  • 干预设计应更充分利用技术、理论及环境政策手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The Surgeon General's Call to Action to Prevent Skin Cancer broadly identified research gaps, but specific objectives are needed to further behavioral intervention research. OBJECTIVE: To review National Institute of Health (NIH) grants targeting skin cancer-related behaviors and relevant outcomes. DESIGN, SETTING, AND PARTICIPANTS: A portfolio analysis of the title, abstract, specific aims, and research plans of identified grant applications from 2000 to 2014 targeting skin cancer-related behaviors or testing behavioral intervention effects on cancer-relevant outcomes along the cancer continuum. MAIN OUTCOMES AND MEASURES: Funding trends were compared along the cancer control continuum, with respect to investigator demographics and use of theory, technology, policy, and changes to environmental surroundings (built environment). RESULTS: A total of 112 submitted applications met inclusion criteria; of these, 40 (35.7%) were funded, and 31 of the 40 were interventions. Comparing the 40 funded grants with the 72 unfunded grants, the overall success rates did not differ significantly between male (33.3%) and female (37.3%) investigators, nor did the frequency of R01 awards (36.7% and 28.1%, respectively). Among intervention awards, most (24 of 31) addressed prevention. Fewer awards targeted detection alone or in conjunction with prevention (3) or cancer survivorship (4), and no grant addressed emotional sequelae or adherence behavior related to diagnosis or treatment. Fewer than half of funded grants aimed for clinically related targets (eg, sunburn reduction). Use of theory and technology occurred in more than 75% of grants. However, the full capability of proposed technology was infrequently used, and rarely did constructs of the proposed behavior change theory clearly and comprehensively drive the intervention approach. Policy or environmental manipulation was present in all dissemination grants but was rarely used elsewhere, and 19.4% included policy implementation and 25.8% proposed changes in built environment. CONCLUSIONS AND RELEVANCE: Grant success rate in skin cancer-related behavioral science compares favorably to the overall NIH grant success rate (approximately 18%), and the success rate of male and female investigators was not statistically different. However, gaps exist in behavioral research addressing all points of the skin cancer control continuum, measuring interventions that hit clinically related targets, and leveraging technology, theory, and environmental manipulation to optimize intervention approach.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Perna FM, Dwyer LA, Tesauro G, et al. Research on Skin Cancer-Related Behaviors and Outcomes in the NIH Grant Portfolio, 2000-2014: Skin Cancer Intervention Across the Cancer Control Continuum (SCI-3C). JAMA Dermatol. 2017. PMID: 28329179. doi:10.1001/jamadermatol.2016.6216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。